Ann Tomlin
Responsable des Ressources Humaines chez LYELL IMMUNOPHARMA, INC.
Profil
Ann Tomlin is currently working as the Senior Vice President-Human Resources at Lyell Immunopharma, Inc. She previously worked as the Head-Human Resources at AbbVie, Inc. and as the Senior Vice President-Human Resources at Myovant Sciences Ltd.
Ms. Tomlin holds a graduate degree from Loyola University of Chicago and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Postes actifs de Ann Tomlin
| Sociétés | Poste | Début |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Responsable des Ressources Humaines | 01/07/2023 |
Anciens postes connus de Ann Tomlin
| Sociétés | Poste | Fin |
|---|---|---|
| MYOVANT SCIENCES LTD. | Responsable des Ressources Humaines | 01/06/2023 |
| ABBVIE INC. | Responsable des Ressources Humaines | - |
Formation de Ann Tomlin
| Loyola University of Chicago | Graduate Degree |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |